High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3

已完结 10 由 CS 发布于 2024/8/2 14:39:03

DOI:10.1016/j.phymed.2020.153171
文献类型：期刊论文
补充材料：仅需补充材料
文献链接：https://doi.org/10.1016/j.phymed.2020.153171

Elsevier

Abstract：Background: Cardiac hypertrophy is a prominent feature of heart remodeling, which may eventually lead to heart failure. Tongmaiyangxin (TMYX) pills are a clinically used botanical drug for t

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:知网浅谈现代通信技术发展现状与未来应用趋势